Cyagen
Founded in 2006, Cyagen is a global provider of genetically modified rodent models and innovative cell and gene therapy solutions for research and development, including disease model development, adeno-associated virus (AAV) discovery, drug efficacy studies and more.
Latest Cyagen Content
Webinar
Accelerating CAR T-Cell Therapy Research for the Fight Against Cancer
On-Demand
Our expert speaker will discuss the current market presence of CAR T cells and the market potential for cell therapy research.
Industry Insight
A One-Stop Platform To Drive Progress in Gene Therapy Development
In this interview, Dr. Ren discusses some of the challenges that currently exist when developing gene therapies and explores how Cyagen’s one-stop gene therapy platform can help to address them.
Advertisement
